close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Betterlife Pharma Inc (CSE:BETR)

0.0500 UNCHANGED
Streaming Delayed Price Updated: 1:13 PM EST, Dec 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Betterlife Pharma Inc

< Previous 1 2 Next >
News headline image
Better Home & Finance Announces Closing of Business Combination
From Better Home & Finance
Via Business Wire
News headline image
BetterLife Highlights American College of Physicians’ Updated Guidelines for Treating Depression and Announces Closing of Private Placement
From BetterLife Pharma Inc.
Via GlobeNewswire
News headline image
BetterLife Fast Tracks Its US Patent for BETR-001 and Other LSD Derivatives
From BetterLife Pharma Inc.
Via GlobeNewswire
News headline image
BetterLife Continues Progress on BETR-001 IND-Enabling Studies
From BetterLife Pharma Inc.
Via GlobeNewswire
News headline image
BetterLife To Present BETR-001 Preclinical Data at the 32nd Annual Meeting of the International Behavioural Neuroscience Society (IBNS) in Niagara Falls, Ontario, Canada
From BetterLife Pharma Inc.
Via GlobeNewswire
News headline image
BetterLife To Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
From BetterLife Pharma Inc.
Via GlobeNewswire
News headline image
BetterLife To Present BETR-001 Preclinical Data at the 2023 Annual Meeting of the Society of Biological Psychiatry (SOBP) in San Diego, California
From BetterLife Pharma Inc.
Via GlobeNewswire
News headline image
Promise of BetterLife's Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Medical Xpress Article
From BetterLife Pharma Inc.
Via GlobeNewswire
News headline image
BetterLife's Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Drug Discovery & Development Article
From BetterLife Pharma Inc.
Via GlobeNewswire
News headline image
BetterLife Announces Engagement of Bloom Burton Securities Inc. and Provides Summary of 2022 Accomplishments
From BetterLife Pharma Inc.
Via GlobeNewswire
News headline image
Betterlife Publishes Promising Results from a Study Titled “A Non-Hallucinogenic LSD Analog With Therapeutic Potential For Mood Disorders”
From BetterLife Pharma Inc.
Via GlobeNewswire
News headline image
BetterLife Announces Closing of Private Placement
From BetterLife Pharma Inc.
Via GlobeNewswire
News headline image
BetterLife To Present BETR-001 Preclinical Data at the 61ST Annual Meeting of the American College of Neuropsychopharmacology (ACNP) in Phoenix, Arizona
From BetterLife Pharma Inc.
Via GlobeNewswire
News headline image
EXCLUSIVE: Can Non-Hallucinogenic Psychedelic Compounds Treat Mental Health Conditions? This Company Thinks So! ↗
Image Provided by Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of... 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today